The US Food and Drug Administration (FDA) has approved a chewable tablet form of extended-release methylphenidate (QuilliChew ER, Pfizer Inc) for attention-deficit/hyperactivity disorder (ADHD) in children aged 6 years and older, the company announced today. The chewable product will be available in tablet form in strengths of 20, 30, and [...]
HUNTINGTON BEACH, California ― Results of a large, multicenter, randomized trial show that extended-release (ER) naltrexone (Vivitrol, Alkermes, Inc) can effectively prevent opioid relapse among a particularly vulnerable population: adults involved in the criminal justice system. "Extended-release naltrexone is better known now, but this study began prior to its approval [...]
What is this new insanity drug of abuse known as gravel or flakka? Recent news reports detail a man, who thought he was being chased by dozens of cars, using every ounce of strength to break the glass of a police station entrance door. Another man ran naked down the [...]
Rexulti: New treatment for schizophrenia and major depressive disorder approved and released by FDA On July 10, the U.S. Food and Drug Administration approved Rexulti (brexpiprazole) tablets to treat adults with schizophrenia and as an add-on treatment to an antidepressant medication to treat adults with major depressive disorder (MDD). [...]
Repetitive training, used widely in autism education, may hinder the learning process by promoting inflexibility, a new study with potentially "earthshaking" implications shows. The study unexpectedly found that repetitive training, a technique widely used in intervention and education for people with autism spectrum disorder (ASD), hinders the learning process by [...]
The Centers for Disease Control and Prevention (CDC) has issued a warning regarding increases in fentanyl drug confiscations and a potential increased risk for fentanyl-related overdose fatalities. According to the CDC, reports from the National Forensic Laboratory Information System, a program of the Drug Enforcement Administration's (DEA's) Office of Diversion [...]
CHICAGO — Taking a probiotic strain of Bifidobacterium longumreduced physiologic and psychological stress and led to a modest improvement in memory in a small pilot study of healthy men. The study builds on preclinical studies that identified this B longumstrain as a "putative psychobiotic" with beneficial effects on stress-related behaviors, [...]
The US Food and Drug Administration (FDA) has approved an injectable, long-acting version of Alkermes Inc's atypical antipsychotic aripiprazole to treat adults with schizophrenia. Aripiprazole lauroxil (Aristada) is administered every 4 to 6 weeks as an injection in the arm or buttocks. The company said it expects to launch the [...]
The US Food and Drug Administration (FDA) has approved the amphetamine Dyanavel XR (Tris Pharma Inc), a once-daily extended-release oral liquid, for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children aged 6 years and older, the company has announced. According to the company, the approval is based on a phase [...]
RESEARCH ARTICLE Selective Serotonin Reuptake Inhibitors and Violent Crime: A Cohort Study Yasmina Molero1, Paul Lichtenstein2, Johan Zetterqvist2, Clara Hellner Gumpert1, Seena Fazel3* 1 Center for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden, 2 Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden, 3 Department of [...]